Research Article
Relationship of Serum IL-12 to Inflammation, Hematoma Volume, and Prognosis in Patients With Intracerebral Hemorrhage
Table 4
Factors associated with 3-month poor outcome in patients with ICH.
| | Variables | Early neurological deterioration | value | | mRS (3–6) (n = 82) | mRS (0–2) (n = 127) |
| | Gender (male/female) | 50/32 | 71/56 | 0.469 | | Age (years) | 69.3 ± 16.8 | 66.1 ± 15.4 | <0.001 | | Admission time (hours) | 6.0 (8.3) | 5.8 (7.2) | 0.389 | | Blood collection time (hours) | 7.0 (7.3) | 6.9 (7.2) | 0.441 | | Initial SBP (mmHg) | 163.5 ± 24.2 | 160.8 ± 26.8 | 0.512 | | Initial DBP (mmHg) | 92.7 ± 19.2 | 92.2 ± 21.3 | 0.869 | | Hypertension (n (%)) | 57 (69.5) | 78 (61.4) | 0.232 | | Current smoking (n (%)) | 29 (35.4) | 38 (29.9) | 0.376 | | Atrial fibrillation (n (%)) | 21 (25.6) | 25 (19.7) | 0.313 | | Lobar hemorrhage (n (%)) | 20 (24.4) | 25 (19.7) | 0.419 | | Infratentorial hemorrhage (n (%)) | 16 (19.5) | 21 (16.5) | 0.582 | | Intraventricular hemorrhage (n (%)) | 21 (25.6) | 28 (22.0) | 0.553 | | Admission NIHSS | 15.5 (9.0) | 7.0 (8.0) | <0.001 | | Hematoma volume (mL) | 19.9 (12.0) | 15.8 (14.5) | 0.005 | | WBC (×109/L) | 10.2 ± 2.8 | 9.4 ± 1.8 | 0.038 | | Serum glucose (mmol/L) | 8.0 ± 1.7 | 7.1 ± 1.2 | 0.041 | | Serum CRP (mg/L) | 25.6 (6.9) | 19.3 (9.8) | <0.001 | | Serum TNF-α (pg/mL) | 69.0 (20.0) | 56.2 (22.0) | <0.001 | | Serum IL-12 (pg/mL) | 79.0 (17.0) | 65.3 (28.6) | <0.001 |
|
|
